성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,782명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

Hepatitis | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000

Hepatitis

NCLEX Review Guide: Hepatitis

Overview of Hepatitis

Definition and Pathophysiology

  • Hepatitis is an inflammation of the liver tissue that can be caused by viral infections, toxins, medications, or autoimmune processes. The inflammation disrupts normal liver function, potentially leading to jaundice, hepatomegaly, and altered liver enzyme levels.
  • The liver's essential functions include metabolism of nutrients, detoxification of harmful substances, synthesis of proteins, and production of biochemicals necessary for digestion, all of which can be compromised during hepatitis.

Key Points

  • Hepatitis primarily affects the hepatocytes (liver cells), causing inflammation and potentially leading to necrosis.
  • The liver's ability to regenerate helps recovery, but chronic inflammation can lead to fibrosis and cirrhosis.

Types of Viral Hepatitis

Hepatitis A (HAV)

  • Hepatitis A is transmitted through the fecal-oral route, commonly from contaminated food or water. It causes an acute, self-limiting infection without chronic sequelae.
  • The incubation period ranges from 15-50 days, with symptoms including fever, malaise, anorexia, nausea, abdominal discomfort, and jaundice that typically resolve within 2 months.

Key Points

  • Hepatitis A never progresses to chronicity and provides lifelong immunity after infection.
  • Prevention includes HAV vaccine, good hand hygiene, and proper food handling.

Hepatitis B (HBV)

  • Hepatitis B is transmitted through exposure to infected blood, semen, and other body fluids. Transmission routes include perinatal, percutaneous, sexual contact, and close person-to-person contact.
  • HBV can cause both acute and chronic infections, with chronicity risk being age-dependent (90% in neonates vs. 5% in adults). The incubation period ranges from 60-150 days.

Key Points

  • HBV serologic markers are crucial for diagnosis: HBsAg (surface antigen) indicates active infection, Anti-HBs indicates immunity, and HBeAg indicates high infectivity.
  • Chronic HBV infection significantly increases the risk of cirrhosis and hepatocellular carcinoma.

Hepatitis C (HCV)

  • Hepatitis C is primarily transmitted through direct contact with infected blood. Risk factors include IV drug use, unscreened blood transfusions (prior to 1992), and unsafe medical procedures.
  • HCV has a high rate of chronicity (75-85% of infected individuals), with many patients remaining asymptomatic for decades until liver damage becomes advanced.

Key Points

  • HCV is the leading cause of liver transplantation in the United States.
  • Direct-acting antiviral (DAA) therapy has revolutionized HCV treatment with cure rates exceeding 95%.

Hepatitis D (HDV)

  • Hepatitis D is a defective virus that requires the presence of HBV for replication. It can occur as a coinfection with HBV or as a superinfection in patients with chronic HBV.
  • HDV superinfection in chronic HBV carriers often leads to more severe liver disease and accelerated progression to cirrhosis.

Key Points

  • HDV infection only occurs in the presence of HBV - prevention of HBV also prevents HDV.
  • HDV superinfection has a worse prognosis than HBV infection alone.

Hepatitis E (HEV)

  • Hepatitis E is transmitted through the fecal-oral route, similar to HAV. It is common in developing countries with poor sanitation and is typically self-limiting.
  • HEV infection has a particularly high mortality rate (up to 25%) in pregnant women, especially during the third trimester.

Key Points

  • HEV is particularly dangerous for pregnant women, unlike other forms of viral hepatitis.
  • Prevention includes safe drinking water, proper sanitation, and food safety.

Commonly Confused Points

Feature Hepatitis A Hepatitis B Hepatitis C
Transmission Fecal-oral Blood, body fluids, sexual contact Primarily blood-borne
Incubation 15-50 days 60-150 days 14-180 days
Chronicity Never chronic 5-10% in adults, 90% in neonates 75-85% of cases
Vaccine Available Available Not available
Prophylaxis Immune globulin (IG) Hepatitis B immune globulin (HBIG) None available

Differentiating Acute vs. Chronic Hepatitis

  • Acute hepatitis is defined as inflammation of the liver lasting less than 6 months, while chronic hepatitis persists beyond 6 months.
  • The transition from acute to chronic infection varies by virus: HAV and HEV typically don't cause chronic disease, HBV chronicity depends on age at infection, and HCV has high chronicity rates regardless of age.

Key Points

  • The 6-month duration is the clinical distinction between acute and chronic hepatitis.
  • Persistent elevation of liver enzymes beyond 6 months suggests chronicity.

Important Alert: Patients with fulminant hepatic failure may develop hepatic encephalopathy, which is a medical emergency requiring immediate intervention. Watch for asterixis, altered mental status, and elevated ammonia levels.

Clinical Manifestations

Common Symptoms

  • Hepatitis often presents with a prodromal phase characterized by fatigue, malaise, anorexia, nausea, vomiting, right upper quadrant pain, and low-grade fever. These symptoms may precede jaundice by 1-2 weeks.
  • The icteric phase is marked by jaundice, dark urine, clay-colored stools, and pruritus due to elevated bilirubin levels and impaired bile excretion.

Key Points

  • Many cases of acute hepatitis are asymptomatic or subclinical, especially in children.
  • Extrahepatic manifestations can include arthralgia, rash, glomerulonephritis, and vasculitis, especially in HBV and HCV.

Physical Examination Findings

  • Physical examination may reveal hepatomegaly (enlarged liver), jaundice (yellowing of skin and sclera), splenomegaly, and spider angiomata in chronic cases.
  • Advanced liver disease may present with ascites, peripheral edema, palmar erythema, gynecomastia, and testicular atrophy due to portal hypertension and altered hormone metabolism.

Key Points

  • Tender hepatomegaly is common in acute hepatitis, while a firm, nodular liver suggests cirrhosis.
  • Jaundice typically becomes clinically apparent when bilirubin levels exceed 2-3 mg/dL.

Clinical Scenario

A 28-year-old male presents to the emergency department with a 1-week history of fatigue, anorexia, and nausea. He noticed yellowing of his eyes and skin 2 days ago. He reports sharing needles while injecting drugs 8 weeks ago. Physical examination reveals icteric sclera, RUQ tenderness, and hepatomegaly. Laboratory results show AST 1200 U/L, ALT 1500 U/L, total bilirubin 4.2 mg/dL, and positive HBsAg.

Question: What is the most likely diagnosis and what precautions should the nurse implement?

Answer: The patient has acute Hepatitis B infection. The nurse should implement standard precautions and contact precautions, especially during handling of blood and body fluids. Education about transmission prevention is essential, and the patient's close contacts should be evaluated for post-exposure prophylaxis.

Diagnostic Evaluation

Laboratory Tests

  • Liver function tests (LFTs): Elevated transaminases (AST and ALT) are hallmarks of hepatitis, often rising to 500-5000 U/L in acute viral hepatitis. ALT is typically higher than AST in viral hepatitis, while the reverse is seen in alcoholic hepatitis.
  • Serologic markers: Specific viral antigens and antibodies help identify the causative virus and stage of infection. For example, HBsAg indicates HBV infection, anti-HAV IgM indicates acute HAV, and anti-HCV indicates exposure to HCV.

Key Points

  • The pattern of LFT elevation can help differentiate between viral, alcoholic, and drug-induced hepatitis.
  • Coagulation studies (PT/INR) reflect the liver's synthetic function and may be prolonged in severe hepatitis.

Imaging Studies

  • Ultrasonography is the initial imaging modality of choice to assess liver size, texture, and rule out biliary obstruction or masses. It may show hepatomegaly and increased echogenicity in acute hepatitis.
  • Computed tomography (CT) and magnetic resonance imaging (MRI) provide more detailed evaluation of liver parenchyma and can detect complications such as ascites, portal hypertension, or hepatocellular carcinoma in chronic cases.

Key Points

  • Imaging studies are not diagnostic for viral hepatitis but help rule out other causes of liver dysfunction.
  • Fibroscan (transient elastography) is a non-invasive method to assess liver fibrosis in chronic hepatitis.

Liver Biopsy

  • Liver biopsy is the gold standard for assessing the severity of liver inflammation, fibrosis, and determining the stage and grade of chronic hepatitis. It is rarely needed for diagnosis of acute viral hepatitis.
  • Histological findings in viral hepatitis include lobular disarray, hepatocyte ballooning, acidophil bodies (apoptotic hepatocytes), and varying degrees of fibrosis in chronic cases.

Key Points

  • Liver biopsy is most useful in chronic hepatitis to guide treatment decisions and assess prognosis.
  • Coagulopathy is a relative contraindication to liver biopsy; PT/INR should be assessed prior to the procedure.

Memory Aid for Hepatitis Serologic Markers

HAV: "A for Acute" - Anti-HAV IgM (acute), Anti-HAV IgG (past infection/immunity)

HBV: "The 3 S's" - Surface (HBsAg/Anti-HBs), Core (Anti-HBc), and Secretory (HBeAg/Anti-HBe)

HCV: "C for Chronic" - Anti-HCV (exposure), HCV RNA (active infection)

Nursing Management

Assessment

  • Perform a comprehensive assessment focusing on risk factors for hepatitis (travel history, sexual practices, IV drug use, occupational exposures, blood transfusions) and current symptoms.
  • Assess for signs of liver dysfunction including jaundice, pruritis, changes in stool/urine color, mental status changes, fluid retention, and bleeding tendencies.

Key Points

  • Regular assessment of mental status is crucial to detect early signs of hepatic encephalopathy.
  • Monitor for complications such as fluid overload, electrolyte imbalances, and coagulopathies.

Nursing Interventions

  1. Implement appropriate isolation precautions based on the type of hepatitis: standard precautions for all patients, contact precautions for HAV and HEV (fecal-oral transmission).
  2. Administer prescribed medications, including antivirals for HBV and HCV, while monitoring for side effects and therapeutic response.
  3. Provide adequate nutrition with small, frequent meals high in carbohydrates and moderate in fat and protein.
  4. Implement measures to reduce pruritus, including cool baths, emollients, and antihistamines as prescribed.
  5. Monitor fluid and electrolyte balance, particularly in patients with ascites or on diuretic therapy.

Key Points

  • Avoid hepatotoxic medications including acetaminophen, NSAIDs, and alcohol.
  • Promote adequate rest balanced with progressive activity as tolerated.

Patient Education

  • Educate patients about the specific type of hepatitis, mode of transmission, and measures to prevent spread to others, including proper handwashing, safe sex practices, and avoiding sharing personal items.
  • Provide dietary guidance emphasizing small, frequent meals, adequate hydration, and avoidance of alcohol and hepatotoxic substances.

Key Points

  • Emphasize the importance of follow-up care and adherence to treatment regimens, especially for chronic hepatitis.
  • Educate about signs and symptoms that require immediate medical attention, such as increased jaundice, mental status changes, or bleeding.

Important Alert: Patients with chronic hepatitis B or C require regular monitoring for hepatocellular carcinoma with alpha-fetoprotein (AFP) levels and liver ultrasound every 6-12 months.

Prevention Strategies

Vaccination

  • Hepatitis A vaccine is recommended for all children aged 12-23 months, travelers to endemic areas, men who have sex with men, injection drug users, and individuals with chronic liver disease or clotting factor disorders.
  • Hepatitis B vaccine is recommended for all infants starting at birth, previously unvaccinated children and adolescents, healthcare workers, and adults at risk due to sexual exposure, injection drug use, or occupational hazards.

Key Points

  • HAV vaccine is given in 2 doses, 6-12 months apart, while HBV vaccine is given in 3 doses at 0, 1, and 6 months.
  • Combined HAV/HBV vaccine (Twinrix) is available for adults requiring both vaccines.

Post-exposure Prophylaxis

  • For Hepatitis A exposure, immune globulin (IG) and/or HAV vaccine should be administered within 2 weeks of exposure to susceptible individuals.
  • For Hepatitis B exposure, hepatitis B immune globulin (HBIG) and/or HBV vaccine should be administered based on exposure type and vaccination status. Infants born to HBsAg-positive mothers should receive HBIG and the first dose of HBV vaccine within 12 hours of birth.

Key Points

  • The effectiveness of post-exposure prophylaxis decreases with time; prompt administration is essential.
  • No effective post-exposure prophylaxis exists for HCV; early screening and treatment is the strategy.

Infection Control Measures

  • Standard precautions, including hand hygiene, use of personal protective equipment, and safe injection practices, are essential for preventing transmission of all types of hepatitis in healthcare settings.
  • Contact precautions are indicated for patients with HAV or HEV who are incontinent or in diapers to prevent fecal-oral transmission.

Key Points

  • Proper hand hygiene is the single most important measure to prevent HAV and HEV transmission.
  • Safe injection practices and needle disposal are critical for preventing HBV and HCV transmission.

Study Tips

Memory Aid for Types of Hepatitis

A - Always spread by Aliments (food/water)

B - Blood and Body fluids

C - Contaminated needles, Chronic infection

D - Depends on B (cannot exist without HBV)

E - Especially dangerous in Expectant mothers

Memory Aid for Hepatitis Complications

"ABCDE" of Chronic Hepatitis Complications:

Ascites

Bleeding (varices)

Coagulopathy

Dementia (hepatic encephalopathy)

Edema

Quick Check Questions

1. Which hepatitis type is most likely to become chronic?

Answer: Hepatitis C (75-85% of cases become chronic)

2. What serologic marker indicates active HBV infection?

Answer: HBsAg (Hepatitis B surface antigen)

3. Which hepatitis types have available vaccines?

Answer: Hepatitis A and Hepatitis B only

4. What is the primary mode of transmission for Hepatitis C?

Answer: Blood-to-blood contact (primarily through contaminated needles/syringes)

Common Pitfalls

  • Don't confuse HAV and HEV - both are fecal-oral transmission, but HEV is particularly dangerous in pregnant women.
  • Remember that HBV vaccine is given IM in the deltoid, not in the gluteal region where absorption may be suboptimal.
  • Don't assume all hepatitis patients need isolation - standard precautions are sufficient for HBV, HCV, and HDV.
  • Avoid confusing the interpretation of HBV serologic markers - HBsAg indicates infection, while anti-HBs indicates immunity.

NCLEX-Style Questions

Practice Questions

  1. A patient with acute hepatitis B asks the nurse when they can return to work as a food server. Which response by the nurse is most appropriate?

    A. "You must wait until your jaundice resolves completely."

    B. "You can return to work immediately as long as you practice good hand hygiene."

    C. "Hepatitis B is not transmitted through food handling, so you can return when you feel physically able."

    D. "You must wait until your HBsAg test is negative."

    Answer: C. Hepatitis B is not transmitted through food handling (it's transmitted through blood and body fluids), so the patient can return to work when physically able.

  2. A nurse is caring for a patient with hepatitis. Which finding would be most concerning and require immediate intervention?

    A. Clay-colored stools

    B. Asterixis and confusion

    C. Pruritus and jaundice

    D. Nausea and anorexia

    Answer: B. Asterixis and confusion indicate hepatic encephalopathy, which is a serious complication requiring immediate intervention.

  3. A nurse is teaching a patient newly diagnosed with chronic hepatitis C. Which statement by the patient indicates understanding of the teaching?

    A. "I need to take my antiviral medications exactly as prescribed to achieve a cure."

    B. "I should get the hepatitis C vaccine to prevent reinfection."

    C. "I cannot transmit the virus to others once I start treatment."

    D. "I should avoid protein in my diet to prevent encephalopathy."

    Answer: A. Taking antiviral medications exactly as prescribed is essential for successful treatment of hepatitis C.

Self-Assessment Checklist








Remember, understanding hepatitis is crucial for providing safe and effective nursing care. Focus on the different types, transmission routes, and prevention strategies. You've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.